Composition

Each tablet contains: Dolutegravir (as Dolutegravir Sodium) 50 mg, Lamivudine 300 mg, Tenofovir Disoproxil Fumarate 300 mg Excipients with known effect: Lactose Monohydrate 150.40 mg. Mannitol 131.38 mg Excipients q.s.  

ATC Code

J05AR27  

Product Category

Drugs

Marketing Category

Prescription-only Medicine (POM)  

Packsize

 

Product Description

Film Coated Tablet White colored, oval shaped, biconvex, film coated tablets, debossed with 'LA75' on one side and plain on the other side 424 Jyna Dolutegravir, Lamivudine And Tenofovir Disopr C4-0363 Dolutegravir, Lamivudine And Tenofovir Disoproxil Dolutegravir Sodium = Sodium (Ras)--{[(-Difluorophenyl)Methyl]Carbamoyl}-- Methyl-,-Dioxo-,,A-Hexahydro- H-Pyrido[’’:]Pyrazino[-B][,]Oxazin--Olate. = Chfnnao Lamivudine = (H)-Pyrimidinone,-Amino--[-(Hydroxyl Methyl)-,-Oxathiolan -Yl]-, (R-Cis)-; Or (-)--[(R,S)--(Hydroxylmethyl)-,-Oxathiolan-Yl]-Cytosine Or (-)--Amino--[(R,S)--(Hydroxymethyl)-,-Oxathiolan-Yl]-Pyrimidin-(H)-One = Chnos Tenofovir Disoproxil Fumarate = -[(R Anti-Infectives Oral (4r,12as)-9-{2,4--4- 6,8-3,4,6,8,12,12a-- 2h-[1’,2’:4,5][2,1-B][1,3]-. = 2(1h)-1-[2--1,3- -5-Yl]-, (2r-Cis)-; Or (-)-1-[(2r,5s)-2-)-1,3--5-Yl]-R (-)-4-Amino-1-[(2r,5s)-2-)-1,3--5--2(1h)- = 9-[(R Tablet, Film Coated Prescription Only Medicine (Pom) Jyna Pharma Ltd Laurus Labs India 2021-05-07 2026-05-06

Manufacturer Name

Laurus Labs Limited

Manufacturer Country

INDIA  

Approval Date

2021-05-07  

Expiry Date

2026-05-06